These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7519862)

  • 21. Modification of primary structures of hairpin ribozymes for probing active conformations.
    Komatsu Y; Kanzaki I; Koizumi M; Ohtsuka E
    J Mol Biol; 1995 Sep; 252(3):296-304. PubMed ID: 7563051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP.
    Koizumi M; Soukup GA; Kerr JN; Breaker RR
    Nat Struct Biol; 1999 Nov; 6(11):1062-71. PubMed ID: 10542100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring post-translational modification of proteins with allosteric ribozymes.
    Vaish NK; Dong F; Andrews L; Schweppe RE; Ahn NG; Blatt L; Seiwert SD
    Nat Biotechnol; 2002 Aug; 20(8):810-5. PubMed ID: 12118241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribozymes: Flexible molecular devices at work.
    Talini G; Branciamore S; Gallori E
    Biochimie; 2011 Nov; 93(11):1998-2005. PubMed ID: 21740954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cis and trans reactions of hairpin ribozymes derived from the negative strand of arabis mosaic virus satellite RNA.
    Tomita R; Morikawa Y; Hisamatsu S; Suzuki-Fujita K; Tanaka T; Sonoki S; Kikuchi Y
    Nucleic Acids Symp Ser; 1995; (34):117-8. PubMed ID: 8841580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
    J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligation of RNA molecules by the hairpin ribozyme.
    Berzal-Herranz A; Burke JM
    Methods Mol Biol; 1997; 74():349-55. PubMed ID: 9204449
    [No Abstract]   [Full Text] [Related]  

  • 28. Group I intron ribozymes.
    Nielsen H
    Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering allosteric regulation into biological catalysts.
    Fastrez J
    Chembiochem; 2009 Dec; 10(18):2824-35. PubMed ID: 19937897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiosyncratic cleavage and ligation activity of individual hammerhead ribozymes and core sequence variants thereof.
    Przybilski R; Hammann C
    Biol Chem; 2007 Jul; 388(7):737-41. PubMed ID: 17570826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding the catalytic repertoire of ribozymes and deoxyribozymes beyond RNA substrates.
    Franzen S
    Curr Opin Mol Ther; 2010 Apr; 12(2):223-32. PubMed ID: 20373266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A ribozyme composed of only two different nucleotides.
    Reader JS; Joyce GF
    Nature; 2002 Dec 19-26; 420(6917):841-4. PubMed ID: 12490955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection in vitro of allosteric ribozymes.
    Roth A; Breaker RR
    Methods Mol Biol; 2004; 252():145-64. PubMed ID: 15017047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA structure. Ribozyme evolution at the crossroads.
    Joyce GF
    Science; 2000 Jul; 289(5478):401-2. PubMed ID: 10939951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro selection of nucleic acids and proteins: What are we learning?
    Roberts RW; Ja WW
    Curr Opin Struct Biol; 1999 Aug; 9(4):521-9. PubMed ID: 10449375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribozyme-catalyzed tRNA aminoacylation.
    Lee N; Bessho Y; Wei K; Szostak JW; Suga H
    Nat Struct Biol; 2000 Jan; 7(1):28-33. PubMed ID: 10625423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and in vitro activity of ribozymes against mRNA of a rat membrane inhibitor of complement.
    Inui O; Tanaka T; Dohi N; Okada N; Okada H; Kikuchi Y
    Nucleic Acids Symp Ser; 1997; (37):223-4. PubMed ID: 9586080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro optimization of truncated stem-loop II variants of the hammerhead ribozyme for cleavage in low concentrations of magnesium under non-turnover conditions.
    Zillmann M; Limauro SE; Goodchild J
    RNA; 1997 Jul; 3(7):734-47. PubMed ID: 9214657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of a ribozyme to a deoxyribozyme through in vitro evolution.
    Paul N; Springsteen G; Joyce GF
    Chem Biol; 2006 Mar; 13(3):329-38. PubMed ID: 16638538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.